Factors contributing to the duration of untreated prodromal positive symptoms in individuals at ultra-high risk for psychosis

Schizophrenia Research

Volumn 162, Issue 1-3, 2015, Pages 64-66

  Chon, Myong Wuk ^a,b   Lee, Tae Young ^c   Kim, Sung Nyun ^a   Huh, Min Jung ^a,b   Park, Hye Youn ^b   Lee, Cho Rong ^d   Shin, Na Young ^d   Kwon, Jun Soo ^a,b,c,d  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Delayed care; Duration of untreated prodromal positive symptoms; Functional decline; Psychosis; Ultra high risk for psychosis

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; FEMALE; FUNCTIONAL DISEASE; GLOBAL ASSESSMENT OF FUNCTIONING; HELP SEEKING BEHAVIOR; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITIVE SYNDROME; PRIORITY JOURNAL; PRODROMAL SYMPTOM; PSYCHOPATHY; PSYCHOSIS; SEX DIFFERENCE; THERAPY DELAY; LONGITUDINAL STUDY; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; PROSPECTIVE STUDY; PSYCHOLOGICAL MODEL; PSYCHOLOGY; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; RISK; TIME TO TREATMENT; YOUNG ADULT;

DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MODELS, PSYCHOLOGICAL; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PRODROMAL SYMPTOMS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; RISK; TIME-TO-TREATMENT; YOUNG ADULT;

EID: 84923218607     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.01.013     Document Type: Article

References (16)

1. Addington J., Cornblatt B.A., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R. At clinical high risk for psychosis: outcome for nonconverters. Am. J. Psychiatry 2011, 168(8):800-805.
2. Apeldoorn S.Y., Sterk B., van den Heuvel E.R., Schoevers R.A., Islam M.A., Genetic R., Outcome of Psychosis I., Bruggeman R., Cahn W., deHaan L., Kahn R.S., Meijer C.J., Myin-Germeys I., van Os J., Wiersma D. Factors contributing to the duration of untreated psychosis. Schizophr. Res. 2014, 158(1-3):76-81.
3. Cocchi A., Lora A., Meneghelli A., La Greca E., Pisano A., Cascio M.T., Preti A., Programma T., Desio Early Intervention Service T. Sex differences in first-episode psychosis and in people at ultra-high risk. Psychiatry Res. 2014, 215(2):314-322.
4. Fusar-Poli P., Meneghelli A., Valmaggia L., Allen P., Galvan F., McGuire P., Cocci A. Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis. Br. J. Psychiatry 2009, 194(2):181-182.
5. Hafner H., Nowotny B., Loffler W., an der Heiden W., Maurer K. When and how does schizophrenia produce social deficits?. Eur. Arch. Psychiatry Clin. Neurosci. 1995, 246(1):17-28.
6. Hall R.C. Global assessment of functioning. A modified scale. Psychosomatics 1995, 36(3):267-275.
7. Jung M.H., Jang J.H., Kang D.H., Choi J.S., Shin N.Y., Kim H.S., An S.K., Shin M.S., Kwon J.S. The reliability and validity of the Korean version of the structured interview for prodromal syndrome. Psychiatry Invest. 2010, 7(4):257-263.
8. Kwon J.S., Byun M.S., Lee T.Y., An S.K. Early intervention in psychosis: insights from Korea. Asian J. Psychiatr. 2012, 5(1):98-105.
9. Lee T.Y., Shin Y.S., Shin N.Y., Kim S.N., Jang J.H., Kang D.H., Kwon J.S. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis. Schizophr. Res. 2014, 153(1):48-53.
10. Miller T.J., McGlashan T.H., Rosen J.L., Cadenhead K., Cannon T., Ventura J., McFarlane W., Perkins D.O., Pearlson G.D., Woods S.W. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 2003, 29(4):703-715.
11. Nelson B., Yuen H.P., Wood S.J., Lin A., Spiliotacopoulos D., Bruxner A., Broussard C., Simmons M., Foley D.L., Brewer W.J., Francey S.M., Amminger G.P., Thompson A., McGorry P.D., Yung A.R. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study. JAMA psychiatry 2013, 70(8):793-802.
12. Penttilä M., Jaaskelainen E., Hirvonen N., Isohanni M., Miettunen J. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br. J. Psychiatry 2014, 205(2):88-94.
13. Schultze-Lutter F., Ruhrmann S., Hoyer C., Klosterkotter J., Leweke F.M. The initial prodrome of schizophrenia: different duration, different underlying deficits?. Compr Psychiatry 2007, 48(5):479-488.
14. Schultze-Lutter F., Ruhrmann S., Berning J., Maier W., Klosterkotter J. Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr. Bull. 2010, 36(1):182-191.
15. Stafford M.R., Jackson H., Mayo-Wilson E., Morrison A.P., Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ 2013, 346(2013):f185.
16. von Reventlow H.G., Kruger-Ozgurdal S., Ruhrmann S., Schultze-Lutter F., Heinz A., Patterson P., Heinimaa M., Dingemans P., French P., Birchwood M., Salokangas R.K., Linszen D., Morrison A., Klosterkotter J., Juckel G. Pathways to care in subjects at high risk for psychotic disorders - a European perspective. Schizophr. Res. 2014, 152(2-3):400-407.